Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Scott Mathis
AddedMar 31, 2024
UpdatedMay 31, 2026
Scott Mathis

Scott Mathis

Board Member, Gaucho Group Holdings

LinkedIn

Scott Mathis's Career

Gaucho Group Holdings
Gaucho Group Holdings

New York City, NY, US

Board Member· Board
Civatech Oncology
Civatech Oncology

Durham, NC, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Scott Mathis's Career

Gaucho Group Holdings
Gaucho Group Holdings
Public$2.2M851999New York City, NY, US
Board Member· Board

Leadership at Gaucho Group Holdings

Marc DumontMarc DumontBoard Member
Bill AllenBill AllenBoard Member

Similar to Gaucho Group Holdings

Standard Luxury GroupStandard Luxury GroupLos Angeles, CA, USFashion, Luxury Goodsest. 2015Standard Luxury GroupLos Angeles, CA, US · est. 2015

Standard Luxury: A global online retailer offering top boutique brands and superior shopping experiences.

Seed · $60k5
Melo GroupMelo GroupMiami, FL, USDevelopment, Real Estateest. 1948Melo GroupMiami, FL, US · est. 1948

Melo Group: A family-owned, full-service real estate firm, developing and managing luxury properties since 1948.

Series D · $217M8
AlpargatasAlpargatasBuenos Aires, Buenos Aires Province, ARFootwear, Textilesest. 2021AlpargatasBuenos Aires, Buenos Aires Province, AR · est. 2021

Alpargatas: An Argentinian textile manufacturer, distributor, and exporter based in Buenos Aires.

3k
GW HoldingsGW HoldingsParadise Valley, AZ, USReal Estateest. 2006GW HoldingsParadise Valley, AZ, US · est. 2006

GW Holdings: A proficient real estate development company.

6
Civatech Oncology
Civatech Oncology
Series A$13.1M422006Durham, NC, US
Board Member· Board

Leadership at Civatech Oncology

Suzanne BabcockSuzanne BabcockBoard Member

Similar to Civatech Oncology

Advanced Chemotherapy TechnologiesAdvanced Chemotherapy TechnologiesRaleigh, NC, USMedical Devicesest. 2014Advanced Chemotherapy TechnologiesRaleigh, NC, US · est. 2014

Advanced Chemotherapy Technologies: Innovating cancer treatment with groundbreaking medical tech solutions.

Series A · $14.9M13
OncurieOncurieRaleigh, NC, USRadiotherapeuticsest. 2021OncurieRaleigh, NC, US · est. 2021

Oncurie, a Raleigh-based software startup, innovates radionuclide tech for metastatic cancer cure.

Angel · $330.7k1
Oncologix TechOncologix TechGrand Rapids, MI, USHealthcare, Medical Devicesest. 1997Oncologix TechGrand Rapids, MI, US · est. 1997

Oncologix Tech Inc.: A healthcare holding company developing radiation therapy devices for soft tissue cancer.

Public191
Radionetics OncologyRadionetics OncologySan Diego, CA, USRadiopharmaceuticalsest. 2021Radionetics OncologySan Diego, CA, US · est. 2021

Radionetics Oncology: Innovating novel radiotherapeutics for diverse oncology treatments.

Series A · $82.5M20

People Similar to Scott Mathis

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiScott MoffittScott MoffittBoard Member · TruWilliam KrollWilliam KrollBoard Member · NuMat TechnologiesMichael KellyMichael KellyBoard Member · FalconStor SoftwareScott DudelsonScott DudelsonBoard Member · PawnGuruMatt LinkMatt LinkBoard Member · IntraVuWill RobbertsWill RobbertsBoard Member · Enable Biosciences